Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12216/293
Title: Supply chain risk assessment in pharmaceutical industries: an empirical approach
Authors: Sreedharan, V. Raja 
Kamala, V. 
Arunprasad, P. 
Issue Date: 2019
Journal: International Journal of Business Innovation and Research 
Abstract: Supply chain risks are one of the significant hurdles faced by the organisations in achieving operational excellence. The purpose of this study is to assess the supply chain risks in the pharmaceutical industries and their influence on supply chain operational performance (SCOP). Through extent literature review, we have identified 44 items which are classified under five constructs consisting of supplier risk (SR), production risk (PR), demand risk (DR), infrastructure risk (IR) and macro risk (MR). Using these constructs, a structured questionnaire has been developed. An online survey was conducted in the pharmaceutical industries yielding a response rate of 66.20%. To validate the hypotheses between these constructs and SCOP, we used Structural equation modelling (SEM). From the SEM result expect demand risks, all other threats have the negative relationship with SCOP (i.e., the higher the chances, the lower the SCOP).Further, to rank the organisation based on their SCOP, we proposed a supply chain risk assessment index (SCRAI) based on the ratings obtained from the experts using Fuzzy techniques. From these results, it is clear that SCRAI is essential for evaluating the organisation's efficiency on supply chain operations.
URI: http://hdl.handle.net/20.500.12216/293
DOI: 10.1504/IJBIR.2019.098769
Appears in Collections:Articles

Show full item record

SCOPUSTM   
Citations

1
Last Week
0
Last month
checked on Dec 12, 2019

Page view(s)

1
Last Week
0
Last month
0
checked on Dec 15, 2019

Google ScholarTM

Check

Altmetric

Altmetric


Items in Corepaedia are protected by copyright, with all rights reserved, unless otherwise indicated.